Inventor · disambiguated record
Pingming Tang
Also filed as: Tang Pingming
3 granted patents·33 pending applications·8 citations·filing 2020–2025
59Inventor score
Files withXIZANG HAISCO PHARMACEUTICAL CO LTD24SICHUAN HAISCO PHARMACEUTICAL CO LTD6HAISCO PHARMACEUTICALS PTE LTD4HAISCO PHARMACEUTICAL GROUP CO LTD2
Top patents by PatentIndex Score
36 records- 0192US11807635B2Nitrile derivative that acts as inhibitor of dipeptidyl peptidase 1 and use thereofHAISCO PHARMACEUTICALS PTE LTD·Filed 2022·Granted Nov 7, 2023·5 cites·12 claims
- 0286US11542266B1Substituted piperidines as BTK inhibitorsHAISCO PHARMACEUTICALS PTE LTD·Filed 2021·Granted Jan 3, 2023·3 cites·19 claims
- 0374US12365673B2Nitrile derivative that acts as inhibitor of dipeptidyl peptidase 1 and use thereofHAISCO PHARMACEUTICALS PTE LTD·Filed 2023·Granted Jul 22, 2025·0 cites·6 claims
- 0468US2025340555A1Tricyclic Fused Heterocyclic PDE3/4 Dual Inhibitor and Use ThereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 0567US2025059186A1Tricyclic Fused Heterocyclic PDE3/4 Dual Inhibitor and Use ThereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0662US2025263426A1Pde4b inhibitor and use thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0759US2025171436A1Tricyclic Fused Heterocyclic PDE3/4 Dual Inhibitor and Use ThereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0859US2025145627A1METTL3 Inhibitor and Composition, and Application of Same in MedicineXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0959US2025340532A1Heterocyclic compound ccr4 inhibitor and user thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1059US2024383917A1Benzo nitrogen-containing heteroaromatic ring derivative and use thereof in medicineXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1158US2025000988A1Epha2 bicyclic peptide ligand and conjugate thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1258US2025346571A1Bicyclic derivative parp inhibitor and use thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1357US2025195485A1Propionic acid derivative and medical use thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1457US2025333410A1Compound for inhibiting or degrading bcl6 and use thereof in pharmaceuticsXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1556US2024391937A1Bicyclic derivative parp inhibitor and use thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1656US2024208932A1Arylamino derivative estrogen receptor modulator and use thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1756US2024043416A1Salt and crystal form of ha inhibitor compoundSICHUAN HAISCO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1856US2025034168A1Nitrogen-containing heterocyclic derivative parp inhibitor and use thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1956US2025382289A1Pyrazolopyridine derivative and application thereof in medicineXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 2055US2024067633A1Ketohexokinase inhibitor and use thereofSICHUAN HAISCO PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2155US2025222116A1Parp-1 degradation agent and use thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2255US2024343720A1Aak1 inhibitor and use thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2355US2025084101A1Compound for inhibiting and degrading irak4, and pharmaceutical composition and pharmaceutical application thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 2454US2024124470A1Five-membered ring derivative and medical use thereofSICHUAN HAISCO PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2554US2024368204A1Small molecular cd73 antagonist and use thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2653US2025215008A1Preparation and use of quinazolinone derivative as kinase inhibitorHAISCO PHARMACEUTICAL GROUP CO LTD·Filed 2023·Application pending·0 cites
- 2753US2025171417A1Heterocyclic derivative, and composition and pharmaceutical use thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2852US2024317736A1Deuterated derivative as atx inhibitor, and application thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2952US2024400586A1Heteroaryl derivative parp inhibitor and use thereofHAISCO PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
- 3051US2024408085A1Compound for degradation of bcl-2 family proteins and medical application thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 3150US2023248833A1Compound having btk kinase degrading activity, and preparation method and pharmaceutical use thereforSICHUAN HAISCO PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 3250US2024269298A1Phosphonyl derivative, and composition and pharmaceutical application thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 3349US2023357193A1Compound capable of inhibiting and degrading androgen receptors, and pharmaceutical compositions and pharmaceutical uses thereofSICHUAN HAISCO PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 3449US2023069174A1Nitrogen-containing heterocyclic autotaxin inhibitor, and composition containing same and use thereofSICHUAN HAISCO PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 3549US2024383874A1Benzene ring derivative, and composition and pharmaceutical use thereofXIZANG HAISCO PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 3649US2023365541A1Inhibitor of enhancer of zeste homologue 2, and use thereofHAISCO PHARMACEUTICALS PTE LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pingming Tang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →